Liver dysfunction related to hepatitis B and C in patients with inflammatory bowel disease treated with immunosuppressive therapy

Loras, Carme; P. Gisbert, Javier; Mínguez, Miguel; Merino, Olga; Bujanda, Luís; Morales Saro, Cristina; Domènech, Eugeni; Barrio, Jésus; Andreu, Montserrat; Ordás, Íngrid; Vida, LN; Bastida, Guillermo; Gónzalez‐Huix, Ferrán; Piqueras, Marta; Ginard, Daniel; Calvet, Xavier; Gutiérrez, A; Abad, Á; Torres, M.; Panés, Julián; Chaparro, María; Pascual, Isabel; Rodríguez‐Carballeira, Mónica; Fernández‐Bañares, Fernando; Viver, J.M.; Esteve, María; the REPENTINA study, for; (Grupo Español de Enfermedades de Crohn y Colitis Ulcerosa) Group, GETECCU

doi:10.1136/gut.2010.208413

Public

Liver dysfunction related to hepatitis B and C in patients with inflammatory bowel disease treated with immunosuppressive therapy

Published in Gut • Jun 24, 2010

Authors:

Carme Loras

Javier P. Gisbert

Miguel Mínguez

Abstract

BACKGROUND: There is no information about the frequency of liver dysfunction in patients with inflammatory bowel disease (IBD) treated with immunosuppressants and infected with hepatitis B (HBV) and/or C virus (HCV). AIM: To assess the influence of immunosuppressants on the course of HBV and HCV inf...

Subject

Medicine

Internal medicine

HBsAg

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!